Literature DB >> 9364555

A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection.

F Mutapi1, P D Ndhlovu, P Hagan, M E Woolhouse.   

Abstract

Antibody responses to Schistosoma haematobium of 280 Zimbabweans were studied in two areas of differing infection levels. 133 of the subjects came from a low infection area with a prevalence of 33.8% and geometric mean infection intensity of 0.8 eggs per 10ml of urine, while 147 of the subjects came from a high infection area with a prevalence of 62.7% and geometric mean intensity of 3.2 eggs per 10 ml of urine. Both the age-prevalence and age-intensity curves exhibited a peak shift. IgA, IgE, IgG, IgG1, IgG2, IgG3, IgG4, and IgM antibody levels against soluble egg antigen (SEA) and whole worm homogenate (WWH) were assayed by ELISA. Females produced significantly more anti-SEA IgG1, IgG4, IgM, anti-WWH IgE and IgG1. People from the high infection area produced significantly more anti-SEA IgE, IgG3 and anti-WWH IgG3 and significantly lower levels of anti-SEA IgA, IgM and anti-WWH IgM when the effects of infection intensity, sex and age had been allowed for. The age profiles of anti-SEA IgA, IgG and anti-WWH IgA and IgM reflected current levels of infection while anti-WWH IgG1, IgG2 and anti-SEA IgG1 evolved more slowly with age, and anti-WWH IgE rose with age in both areas. Some antibody responses, anti-SEA/WWH IgM, anti-SEA IgG1 and possibly anti-SEA/ WWH IgA showed different age profiles in the two areas, with changes in antibody levels occurring at a younger age in the high infection area suggesting that immune responses are evolving more rapidly in residents of this area. This result clearly demonstrates that antibody levels are not a function of age alone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364555     DOI: 10.1046/j.1365-3024.1997.d01-206.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  42 in total

1.  Cytokine production in whole blood cultures from a fishing community in an area of high endemicity for Schistosoma mansoni in Uganda: the differential effect of parasite worm and egg antigens.

Authors:  Sarah Joseph; Frances M Jones; Gachuhi Kimani; Joseph K Mwatha; Timothy Kamau; Francis Kazibwe; Jovanice Kemijumbi; Narcis B Kabatereine; Mark Booth; Henry C Kariuki; John H Ouma; Birgitte J Vennervald; David W Dunne
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.

Authors:  F C Cardoso; R N A Pacífico; R A Mortara; S C Oliveira
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms.

Authors:  Kate M Mitchell; Francisca Mutapi; Nicholas J Savill; Mark E J Woolhouse
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

4.  Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

Authors:  Carla L Black; Erick M O Muok; Pauline N M Mwinzi; Jennifer M Carter; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

5.  A new approach to characterize populations of Schistosoma mansoni from humans: development and assessment of microsatellite analysis of pooled miracidia.

Authors:  B Hanelt; M L Steinauer; I N Mwangi; G M Maina; L E Agola; G M Mkoji; E S Loker
Journal:  Trop Med Int Health       Date:  2009-01-28       Impact factor: 2.622

6.  Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.

Authors:  Francisca Mutapi; Nadine Rujeni; Claire Bourke; Kate Mitchell; Laura Appleby; Norman Nausch; Nicholas Midzi; Takafira Mduluza
Journal:  PLoS Negl Trop Dis       Date:  2011-05-17

7.  Anti-Schistosoma IgG responses in Schistosoma haematobium single and concomitant infection with malaria parasites.

Authors:  Olajumoke A Morenikeji; Olumide Adeleye; Ewean C Omoruyi; Oyetunde T Oyeyemi
Journal:  Pathog Glob Health       Date:  2016-04-19       Impact factor: 2.894

8.  Immunoepidemiology of Wuchereria bancrofti infection: parasite transmission intensity, filaria-specific antibodies, and host immunity in two East African communities.

Authors:  Walter G Jaoko; Edwin Michael; Dan W Meyrowitsch; Benson B A Estambale; Mwele N Malecela; Paul E Simonsen
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

9.  Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children.

Authors:  Laura J Appleby; Norman Nausch; Claire D Bourke; Nadine Rujeni; Nicholas Midzi; Takafira Mduluza; Judith E Allen; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2012-11-08

10.  Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies.

Authors:  N Rujeni; N Nausch; N Midzi; T Mduluza; D W Taylor; F Mutapi
Journal:  Parasite Immunol       Date:  2012-06       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.